BTNL2 inhibits T-cell proliferation, thereby linking BTNL2 polymorphisms with inflammatory/’autoimmune’ diseases such as sarcoidosis or myositis [62–64]. The gene discussed is BTNL2; the disease is glycogen storage disease VI.